RABUMAN BERNA Injection
Immunoglobulin - antirabis (human)
300 IU
BERNA [SWISS SERUM & VACCINE INST.]
| Pack size | 2ml Vial |
|---|---|
| Dispensing mode | POM |
| Source | SWITZERLAND |
| Agent | Modern Pharmaceutical Co. |
| Retail Price | 383.50 AED |
Available as:
Indications
RABUMAN BERNA Injection is used for:
For use in prophylaxis against rabies virus in patients who have been exposed to the virus and are immunocompromised or have not previously recieved the rabies vaccine [FDA Label].
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Immunoglobulin - antirabis (human) :
Mechanism of Action
Rabies immune globulin binds the rabies virus, preventing it from invading the central nervous system [FDA Label]. This affords time for the rabies vaccine, which is also administered in cases of rabies exposure, to induce an immune response to destroy the virus. Rabies immunoglobulin should only be administered up to eight days after exposure as the host begins to produce sufficient antibodies to the virus one week after exposure. Repeat dosing should also be avoided as it may interfere with induction of immune response by the rabies vaccine.
Note
RABUMAN BERNA 300 IU Injection manufactured by BERNA [SWISS SERUM & VACCINE INST.]. Its generic name is Immunoglobulin - antirabis (human). RABUMAN BERNA is availble in United Arab Emirates.
Farmaco UAE drug index information on RABUMAN BERNA Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.